These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32104392)

  • 1. Combretastatin A4/poly(
    Ou Y; Tang ZH; Sun L; Yu HY; Li J; Zhao MH; Xu H
    Asian J Pharm Sci; 2018 Mar; 13(2):191-196. PubMed ID: 32104392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(L-Glutamic Acid)-Drug Conjugates for Chemo- and Photodynamic Combination Therapy.
    Yu H; Bao Y; Xu C; Chen L; Tang Z
    Macromol Biosci; 2021 Jan; 21(1):e2000192. PubMed ID: 33043592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A poly(l-glutamic acid)-combretastatin A4 conjugate for solid tumor therapy: Markedly improved therapeutic efficiency through its low tissue penetration in solid tumor.
    Liu T; Zhang D; Song W; Tang Z; Zhu J; Ma Z; Wang X; Chen X; Tong T
    Acta Biomater; 2017 Apr; 53():179-189. PubMed ID: 28167300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A UHPLC-MS/MS method coupled with simple and efficient alkaline hydrolysis for free and total determination of conjugate nanomedicine: Pharmacokinetic and biodistribution study of poly (l-glutamic acid)-graft-methoxy poly (ethylene glycol)/combretastatin A4.
    Zeng Q; Liu Y; Song Y; Feng B; Xu P; Shan B; Liao Z; Liu K; Zhong Y; Chen L; Su D
    J Pharm Biomed Anal; 2019 May; 169():215-224. PubMed ID: 30877933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles Composed of PEGylated Alternating Copolymer-Combretastatin A4 Conjugate for Cancer Therapy.
    Zhang Y; Liu X; Wang X; He P; Xiao C; Yu H; Chen X
    Macromol Biosci; 2021 Aug; 21(8):e2100077. PubMed ID: 34031970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-administration of combretastatin A4 nanoparticles and sorafenib for systemic therapy of hepatocellular carcinoma.
    Wang Y; Yu H; Zhang D; Wang G; Song W; Liu Y; Ma S; Tang Z; Liu Z; Sakurai K; Chen X
    Acta Biomater; 2019 Jul; 92():229-240. PubMed ID: 31100462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Amplifying Nanotherapeutic Drugs Homing to Tumors in a Manner of Chain Reaction.
    Wang Y; Shen N; Wang Y; Zhang Y; Tang Z; Chen X
    Adv Mater; 2021 Feb; 33(7):e2002094. PubMed ID: 33382144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI3Kgamma Inhibitor Attenuates Immunosuppressive Effect of Poly(l-Glutamic Acid)-Combretastatin A4 Conjugate in Metastatic Breast Cancer.
    Qin H; Yu H; Sheng J; Zhang D; Shen N; Liu L; Tang Z; Chen X
    Adv Sci (Weinh); 2019 Jun; 6(12):1900327. PubMed ID: 31380170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced anti-PD-1 therapy in hepatocellular carcinoma by tumor vascular disruption and normalization dependent on combretastatin A4 nanoparticles and DC101.
    Bao X; Shen N; Lou Y; Yu H; Wang Y; Liu L; Tang Z; Chen X
    Theranostics; 2021; 11(12):5955-5969. PubMed ID: 33897892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formula optimization and in vivo study of poly(L-glutamic acid)-g-methoxy poly(ethylene glycol)/combretastatin A4/BLZ945 nanoparticles for cancer therapy.
    Huang Y; Yang C; Lv J; Zhang Y; Wang K; Ma L; Liu Z; Yu H; Li M; Tang Z
    Int J Pharm; 2023 Apr; 636():122849. PubMed ID: 36933582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and Characterization Evaluation of Poly(L-Glutamic Acid)-
    Guo D; Huang Y; Wang K; Yang C; Ma L; Zhang Y; Yu H; Cui M; Tang Z
    Int J Nanomedicine; 2023; 18():6901-6914. PubMed ID: 38026524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
    Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
    PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combretastatin A4-β-Galactosyl Conjugates for Ovarian Cancer Prodrug Monotherapy.
    Doura T; Takahashi K; Ogra Y; Suzuki N
    ACS Med Chem Lett; 2017 Feb; 8(2):211-214. PubMed ID: 28197314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FXIIIa substrate peptide decorated BLZ945 nanoparticles for specifically remodeling tumor immunity.
    Wei Q; Shen N; Yu H; Wang Y; Tang Z; Chen X
    Biomater Sci; 2020 Oct; 8(20):5666-5676. PubMed ID: 33049011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin Loaded Poly(L-glutamic acid)-g-Methoxy Poly(ethylene glycol) Complex Nanoparticles for Potential Cancer Therapy: Preparation, In Vitro and In Vivo Evaluation.
    Yu H; Tang Z; Li M; Song W; Zhang D; Zhang Y; Yang Y; Sun H; Deng M; Chen X
    J Biomed Nanotechnol; 2016 Jan; 12(1):69-78. PubMed ID: 27301173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combretastatin A4 Nanoparticles Combined with Hypoxia-Sensitive Imiquimod: A New Paradigm for the Modulation of Host Immunological Responses during Cancer Treatment.
    Shen N; Wu J; Yang C; Yu H; Yang S; Li T; Chen J; Tang Z; Chen X
    Nano Lett; 2019 Nov; 19(11):8021-8031. PubMed ID: 31558024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted treatment of choroidal neovascularization using integrin-mediated sterically stabilized liposomes loaded with combretastatin A4.
    Ma L; Liu YL; Ma ZZ; Dou HL; Xu JH; Wang JC; Zhang X; Zhang Q
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):195-200. PubMed ID: 19456253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects and underlying mechanism of poly (L-glutamic acid)-
    Chen J; Yin M; Yang C; Wang K; Ma L; Yu H; Huang Y; Liu F; Tang Z
    Front Bioeng Biotechnol; 2024; 12():1336692. PubMed ID: 38375454
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor Microenvironment Remodeling-Mediated Sequential Drug Delivery Potentiates Treatment Efficacy.
    Xu Y; Lv J; Liu F; Wang J; Liu Y; Kong C; Li Y; Shen N; Gu Z; Tang Z; Chen X
    Adv Mater; 2024 Jun; 36(23):e2312493. PubMed ID: 38444177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covalent functionalization of SWCNT with combretastatin A4 for cancer therapy.
    Assali M; Zaid AN; Kittana N; Hamad D; Amer J
    Nanotechnology; 2018 Jun; 29(24):245101. PubMed ID: 29583132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.